ArticleHuman vaccines & immunotherapeutics2022

Model-based estimation of the impact on rotavirus disease of RV3-BB vaccine administered in a neonatal or infant schedule.

Nicholas Geard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.